Skip to content

Menu

Takeda Pharmaceuticals Australia Pty Ltd

Takeda Pharmaceuticals Australia Pty Ltd: $486,619,056 in recorded Commonwealth contract awards across 3 contracts and 1 agencies.

Updated 2026-10-23. Source: AusTender, Department of Finance. Latest contract notice per amendment lineage.. Award values are not expenditure. One contract is counted at its latest recorded notice value; amendments are not added together. Coverage is limited to the available notices.

Agencies contracted

Filters
Agency
Agency
Value
Value
Columns
Visible columns
Contracts
0–$434.1mActions
Procurement of Imported Plasma and Recombinant Products (IPRP) – Adynovate$22.3m30 Jun 2025
Imported Plasma and Recombinant Products$30.2m30 Sep 2022
National Supply arrangement for imported immunoglobulin products$434.1m31 Dec 2020
Notice details for the largest awards
  1. CBP-CON-00175 — National Supply arrangement for imported immunoglobulin products. $434,085,725. Start date: 2020-12-31. Published: 2026-06-09. Agency: National Blood Authority. AusTender notice CN3743080.
  2. CBP-CON-00172 — Imported Plasma and Recombinant Products. $30,209,374. Start date: 2022-09-30. Published: 2026-07-16. Agency: National Blood Authority. AusTender notice CN3924657.
  3. CBP-CON-00154 — Procurement of Imported Plasma and Recombinant Products (IPRP) – Adynovate. $22,323,958. Start date: 2025-06-30. Published: 2025-07-18. Agency: National Blood Authority. AusTender notice CN4171512.

Other suppliers to these agencies

National Blood Authority

An association does not prove influence.

Browse suppliers · Sources and methods